PP6.4 – 00096 Therapeutic efficacy of AAV-delivered HIV-1 bNAbs to prevent SHIV rebound in Rhesus macaques

Journal of Virus Eradication · Published 2024-12-01 · DOI 10.1016/j.jve.2024.100519

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.jve.2024.100519

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2024

Related articles

PP7.8 – 00085 Readiness for analytic treatment interruption trials among early treated children well-suppressed on antiretroviral therapy – willingness to participate, HIV-1 DNA levels and Western Blot RESULTS: Oral · Journal of Virus Eradication · 2024 · Same journal
Timeliness of the second dose of measles-containing vaccine uptake and its determinants among children aged 24–36 months in Gondar City, Northwest Ethiopia, 2023: Community-based cross-sectional study design · Journal of Virus Eradication · 2025 · Same journal
Inhibition of protein kinase R suppresses HIV replication and integration in CD4 T cells · Journal of Virus Eradication · 2025 · Same journal
Dynamic changes in immune cell subsets in blood and lymph node over the course of acute HIV infection · Journal of Virus Eradication · 2025 · Same journal
PP4.12 – 00068 Persistence and Maturation of B Cell Lineages during ART initiation in Chronic SHIV-infected Juvenile Rhesus Macaques · Journal of Virus Eradication · 2024 · Same journal
Knowledge and willingness towards human Papillomavirus vaccination among the parents and school teachers of eligible girls in Dhaka, Bangladesh: A school-based cross-sectional study · Journal of Virus Eradication · 2025 · Same journal
Legal framework reform imperatives for rabies elimination in Bangladesh · Journal of Virus Eradication · 2026 · Same journal
Human CD123+AXL+ dendritic cells express Siglec1 that captures and transmits HIV-1 particles to the T cells · Journal of Virus Eradication · 2025 · Same journal
Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev) · Journal of Virus Eradication · 2024 · Same journal
2-Deoxyglucose as a therapeutic strategy for EBV-associated gastric carcinoma: Glycolytic and lytic reactivation inhibition under hypoxic conditions · Journal of Virus Eradication · 2025 · Same journal